Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Blood and Marrow Transplant Group of Georgia is a private specialty healthcare provider focused on blood and marrow transplantation, leukemia care, and cellular immunotherapy in partnership with Northside Hospital in Atlanta. The organization operates a large clinical transplant and hematologic malignancy program serving patients with leukemia, lymphoma, multiple myeloma, and related disorders. Its services include autologous and allogeneic stem cell transplantation, CAR-T cell therapy, tumor-infiltrating lymphocyte therapy, outpatient and inpatient hematology care, and access to clinical trials. The physician group appears to function primarily as a clinical care delivery organization rather than a drug development biotech company. It is positioned as one of the larger transplant programs in Georgia and emphasizes transplant outcomes, multidisciplinary care, and specialized facilities for hematologic cancers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on The Blood and Marrow Transplant Group of Georgia.